Cargando…
Guidance on Minimizing Risk of Drug-Induced Ventricular Arrhythmia During Treatment of COVID-19: A Statement from the Canadian Heart Rhythm Society
The COVID-19 pandemic has led to efforts at rapid investigation and application of drugs which may improve prognosis but for which safety and efficacy are not yet established. This document attempts to provide reasonable guidance for the use of antimicrobials which have uncertain benefit but may inc...
Autores principales: | Sapp, John L., Alqarawi, Wael, MacIntyre, Ciorsti J., Tadros, Rafik, Steinberg, Christian, Roberts, Jason D., Laksman, Zachary, Healey, Jeff S., Krahn, Andrew D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Canadian Cardiovascular Society. Published by Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7195336/ https://www.ncbi.nlm.nih.gov/pubmed/32299753 http://dx.doi.org/10.1016/j.cjca.2020.04.003 |
Ejemplares similares
-
The Hearts in Rhythm Organization: A Canadian National Cardiogenetics Network
por: Davies, Brianna, et al.
Publicado: (2020) -
Quinidine effective for the management of ventricular and atrial arrhythmias associated with Brugada syndrome
por: Halperin, Laura, et al.
Publicado: (2018) -
Perceived self-efficacy and empowerment in patients at increased risk of sudden cardiac arrest
por: Davies, Brianna, et al.
Publicado: (2023) -
Management of Inherited Arrhythmia Syndromes: A HiRO Consensus Handbook on Process of Care
por: Janzen, Mikyla L., et al.
Publicado: (2023) -
Importance of genetic testing in unexplained cardiac arrest( )
por: Grondin, Steffany, et al.
Publicado: (2022)